Comparative efficacy and safety of lesinurad 200 mg and 400 mg combined with a xanthine oxidase inhibitor in hyperuricemic patients with gout: A Bayesian network meta-analysis of randomized controlled trials

2019 ◽  
Vol 57 (07) ◽  
pp. 345-352
Author(s):  
Gwan Gyu Song ◽  
Young Ho Lee
Sign in / Sign up

Export Citation Format

Share Document